Evidence map›Paper›PMID 40744942›Full record

ArticleNPJ genomic medicine2025

A founder BRCA1 exonic duplication involving breakpoint in T2T reference genome-specific region results in constitutional fusion transcript.

Mathias Schwartz, Mathilde Filser, Kevin Merchadou, Elisa Lemaitre, Khadija Abidallah, Henrique Tenreiro, Catherine Dubois D'enghien, Audrey Rapinat, Elise Pierre-Noel, Voreak Suybeng and 13 more

Erratum issuedAbstract read
In one paragraph

Article in NPJ genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Mathias SchwartzDepartment of Genetics, Institut Curie, Paris, France. mathias.schwartz@curie.fr.
Mathilde FilserDepartment of Genetics, Institut Curie, Paris, France.
Kevin MerchadouParis Sciences Lettres (PSL) Research University, Paris, France.
Elisa LemaitreDepartment of Genetics, Institut Curie, Paris, France.
Khadija AbidallahDepartment of Genetics, Institut Curie, Paris, France.
Henrique TenreiroDepartment of Genetics, Institut Curie, Paris, France.
Catherine Dubois D'enghienDepartment of Genetics, Institut Curie, Paris, France.
Audrey RapinatParis Sciences Lettres (PSL) Research University, Paris, France.
Elise Pierre-NoelDepartment of Genetics, Institut Curie, Paris, France.
Voreak SuybengDepartment of Genetics, Institut Curie, Paris, France.
Marion EspenelParis Sciences Lettres (PSL) Research University, Paris, France.
Sylvain BaulandeParis Sciences Lettres (PSL) Research University, Paris, France.
Séverine AdamsDepartment of Genetics, Institut Curie, Paris, France.
Audrey RemenierasLaboratoire d'Oncogénétique Moléculaire, Département de Biologie du Cancer, Institut Paoli Calmettes, Marseille, France.
Crystal RenaudLaboratoire de biologie et de génétique du cancer, Centre François Baclesse, Caen, France.
Camille AucouturierLaboratoire de biologie et de génétique du cancer, Centre François Baclesse, Caen, France.
Capucine DelnatteLaboratoire de Génétique Moléculaire, Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France.
Céline GarrecLaboratoire de Génétique Moléculaire, Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France.
Victor RenaultParis Sciences Lettres (PSL) Research University, Paris, France.
Lisa GolmardDepartment of Genetics, Institut Curie, Paris, France.
Emmanuelle FourmeDepartment of Genetics, Institut Curie, Paris, France.
Julien Masliah-Planchon *Department of Genetics, Institut Curie, Paris, France.
Sandrine M Caputo *Department of Genetics, Institut Curie, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenicity assessment of genetic variants is the cornerstone of genetic counselling. Copy gains of exons are challenging, as pathogenicity depends on the localization of the additional exons. Eight patients form six families carried copy gains of BRCA1 exons 8-20. For appropriate characterization, long-read sequencing aligned on three distinct reference genome assemblies, optical genomic mapping, short-read and long-read RNA sequencing were performed. All patients shared the same pathogenic structural variant, involving a large segment located downstream in the genome. One breakpoint occurred in a region incorrectly annotated in GRCh37/hg19 and GRCh38/hg38. Alignment to the T2T-CHM13/hs1 assembly was therefore necessary for accurate characterization. This rearrangement caused various BRCA1 transcriptomic abnormalities: back-splicing, forward genomic strand transcription by insertion of an ectopic promoter, fusion transcripts with the "Next to BRCA1" gene 1 (NBR1). Our findings underscore the need to combine advanced technologies with the latest genome references to resolve complex rearrangements with significant medical implications.

Identifiers

PMID40744942
PMCPMC12314049

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.